オンボディドラッグデリバリーデバイスの世界市場

オンボディドラッグデリバリーデバイスの世界市場は2030年までに5億6,260万米ドルに達する見込み

2024年に4億490万米ドルと推定されるオンボディドラッグデリバリーデバイスの世界市場は、2030年には5億6,260万米ドルに達し、分析期間2024-2030年のCAGRは5.6%で成長すると予測されます。本レポートで分析したセグメントの1つであるウェアラブル注射器は、CAGR 4.3%を記録し、分析期間終了時には1億7,890万米ドルに達すると予測されます。自動注射器セグメントの成長率は、分析期間でCAGR 6.7％と推定されます。

米国市場は1億1,030万米ドルと推定、中国はCAGR 8.6％で成長予測

米国のオンボディドラッグデリバリーデバイス市場は、2024年に1億1,030万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを8.6%として、2030年までに1億1,180万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9%と5.5%と予測されています。欧州では、ドイツがCAGR 3.6%で成長すると予測されています。

世界のオンボディドラッグデリバリーデバイス市場- 主要動向と促進要因のまとめ

なぜオンボディドラッグデリバリーデバイスが慢性疾患管理と生物学的製剤投与に革命を起こすのか？

オンボディドラッグデリバリーデバイス（OBDD）は、ウェアラブルで事前にプログラムされたシステムにより、患者が自宅で治療を自己管理できるようにすることで、生物製剤や長時間作用型注射療法の投与を再定義しています。これらのデバイスは皮膚に貼付し、数分から数時間かけて薬剤を投与するもので、頻繁な通院、皮下注射、静脈注射に代わるものです。OBDDの台頭は、がん、糖尿病、自己免疫疾患、心血管疾患など、長期にわたる薬物療法を必要とする慢性疾患の有病率の増加と一致しています。

OBDDの需要は、医療システムが入院コストの削減と分散型治療モデルによる患者のQOLの向上を目指すバリュー・ベース・ケアへのシフトによって牽引されています。OBDDは、投与回数の削減、薬物動態の改善、患者のコンプライアンス向上といったメリットをもたらします。OBDDの魅力は、モノクローナル抗体、チェックポイント阻害剤、サイトカイン療法を皮下投与できる腫瘍学と免疫学において特に強いです。これらのデバイスをデジタルヘルスエコシステムに統合することで、遠隔モニタリング、リアルタイムのアドヒアランス追跡、臨床転帰の最適化がさらにサポートされます。

デザイン革新とデジタル統合は、どのようにオンボディデリバリープラットフォームの有用性と受容性を高めているのか？

最新のオンボディドラッグデリバリーデバイスは、使いやすさ、安全性、患者の快適性を確保するために、高度なエレクトロニクス、マイクロ流体ポンプ、ウェアラブルに適した素材で設計されています。ほとんどのデバイスは、一体型粘着パッチ、自動薬物再構成機構、状態や完了のための可聴/視覚インジケータを含む、単回使用のバッテリー駆動システムです。コンパクトなフォームファクター、カスタマイズ可能な投与レジメン、温度制御機能により、多様な薬物タイプや患者層で使いやすさが拡大しています。

OBDDとデジタル治療薬およびコネクテッド・ヘルス・プラットフォームとの融合が進むことは、重要な技術革新分野です。Bluetooth対応のOBDDは現在、投与確認、タイムスタンプ、機器診断をモバイルアプリやクラウドベースの医師ポータルに送信することができます。このような接続性により、パーソナライズされた投与リマインダー、有害事象報告、非服薬アドヒアランスへの介入が可能になります。AI主導の分析が使用データに適用され、投与遅延の予測、治療の個別化の強化、高リスク患者コホートの特定が可能になります。このようなスマートな機能により、OBDDは受動的な機器から、より広範な継続的ケアの中でのダイナミックなツールへと変貌しつつあります。

体内ドラッグデリバリーシステムの採用を加速させている治療分野と地域市場は？

オンボディドラッグデリバリーの最大の応用分野はがん領域であり、特に乳がん、肺がん、血液悪性腫瘍に使用されるモノクローナル抗体療法に適しています。アムジェンのNeulasta Onproのようなデバイスは、病院への再来院を必要とせず、化学療法後の支持療法へのアクセスを改善することで、市場への強い浸透を示しています。関節リウマチ、クローン病、乾癬などの免疫疾患も主要な市場であり、アダリムマブやウステキヌマブのような生物学的製剤がウェアラブルデリバリー用に改良されつつあります。

北米は、生物学的製剤の採用率が高いこと、償還制度が充実していること、配合剤に関する薬事規制が良好であることから、市場をリードしています。欧州は、慢性疾患の蔓延と在宅医療システムの拡大に支えられ、僅差で続いています。アジア太平洋は、特に日本と韓国において、高齢化社会と高度な医薬品インフラがOBDD採用に有利な条件を作り出している成長フロンティアです。新興市場では、製薬企業とのパートナーシップや遠隔医療を可能にするアウトリーチプログラムが、アクセスギャップを埋めるのに役立っており、OBDDを地域レベルの慢性疾患ケアモデルの重要な要素として位置づけています。

オンボディドラッグデリバリーデバイス市場の長期的成長と戦略的革新の原動力は何か？

オンボディドラッグデリバリーデバイス市場の成長の原動力は、生物学的製剤の使用量の増加、患者中心のケアモデルの進化、ヘルスケアシステムの負担軽減の必要性です。COVID-19のパンデミックは、自己投与治療へのシフトを加速させ、システムの混乱時に治療の継続性を確保するOBDDの重要性を浮き彫りにしました。アウトカムベースの償還に対する支払者の関心の高まりも、アドヒアランスと実際の有効性を向上させる技術の採用を促しています。

デバイスメーカーは、様々な容量、粘度、薬剤の安定性をサポートするモジュール式プラットフォームに投資しています。リサイクル可能なコンポーネントやプラスチック使用量の削減を含む持続可能な設計は、環境問題への監視の中で重要性を増しています。バイオテクノロジー企業と医療機器メーカーの共同開発パートナーシップは標準的なものとなりつつあり、医薬品と医療機器の組み合わせによる製品の迅速な承認取得と市場参入を可能にしています。生物学的製剤が医薬品パイプラインの大半を占め続け、デジタルヘルスが慢性疾患管理に不可欠になるにつれて、体内送達デバイスは、従来の臨床環境を超えて専門医療の範囲を拡大する多機能でインテリジェントな健康のお供へと進化します。

セグメント

製品タイプ（ウェアラブル注射器、自動注射器、パッチ、その他製品タイプ）、用途（心血管疾患用途、がん用途、自己免疫疾患用途、糖尿病用途、その他用途）、最終用途（病院最終用途、専門クリニック最終用途、外来手術センター最終用途、その他最終用途）

調査対象企業の例（注目32社）

• Ablitech, Inc.
• BD（Becton, Dickinson and Company）
• BioSapien Inc.
• Coherus BioSciences, Inc.
• Convatec Group plc
• Eitan Medical
• Elcam Medical
• Enable Injections
• Gerresheimer AG
• Intarcia Therapeutics
• Johnson & Johnson
• Medtronic plc
• Nemera
• NOVO Engineering
• Phillips-Medisize
• Roche Holding AG
• SHL Medical
• Stevanato Group
• Tandem Diabetes Care, Inc.
• Ypsomed AG

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global On-Body Drug Delivery Devices Market to Reach US$562.6 Million by 2030

The global market for On-Body Drug Delivery Devices estimated at US$404.9 Million in the year 2024, is expected to reach US$562.6 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Wearable Injectors, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$178.9 Million by the end of the analysis period. Growth in the Auto-injectors segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$110.3 Million While China is Forecast to Grow at 8.6% CAGR

The On-Body Drug Delivery Devices market in the U.S. is estimated at US$110.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$111.8 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global On-Body Drug Delivery Devices Market - Key Trends & Drivers Summarized

Why Are On-Body Drug Delivery Devices Revolutionizing Chronic Disease Management and Biologic Administration?

On-body drug delivery devices (OBDDs) are redefining the administration of biologics and long-acting injectable therapies by enabling patients to self-administer treatments in a home setting through wearable, pre-programmed systems. These devices are adhered to the skin and deliver medications over minutes to hours, offering an alternative to frequent hospital visits, subcutaneous injections, or intravenous infusions. Their rise coincides with the increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular conditions that require long-term pharmacologic adherence.

The demand for OBDDs is being driven by the shift toward value-based care, where healthcare systems aim to reduce hospitalization costs and improve patient quality of life through decentralized treatment models. These devices offer benefits such as reduced dosing frequency, improved pharmacokinetics, and enhanced patient compliance. Their appeal is particularly strong in oncology and immunology, where monoclonal antibodies, checkpoint inhibitors, and cytokine therapies can be delivered subcutaneously using OBDDs. The integration of these devices into digital health ecosystems further supports remote monitoring, real-time adherence tracking, and clinical outcome optimization.

How Are Design Innovations and Digital Integration Enhancing the Utility and Acceptance of On-Body Delivery Platforms?

Modern on-body drug delivery devices are engineered with advanced electronics, microfluidic pumps, and wearable-friendly materials to ensure ease of use, safety, and patient comfort. Most devices are single-use, battery-powered systems that include integrated adhesive patches, automated drug reconstitution mechanisms, and audible/visual indicators for status and completion. Compact form factors, customizable dosing regimens, and temperature control functionalities are expanding usability across diverse drug types and patient demographics.

The growing convergence of OBDDs with digital therapeutics and connected health platforms is a key innovation area. Bluetooth-enabled OBDDs can now transmit dose confirmation, time stamps, and device diagnostics to mobile apps or cloud-based physician portals. Such connectivity allows for personalized dosing reminders, adverse event reporting, and intervention for non-adherence. AI-driven analytics are being applied to usage data to predict dose delays, enhance treatment personalization, and identify high-risk patient cohorts. These smart capabilities are transforming OBDDs from passive devices into dynamic tools within the broader continuum of care.

Which Therapeutic Areas and Regional Markets Are Accelerating the Adoption of On-Body Drug Delivery Systems?

The oncology sector is the largest application area for on-body drug delivery, especially for monoclonal antibody therapies used in breast cancer, lung cancer, and hematologic malignancies. Devices like Amgen’s Neulasta Onpro have demonstrated strong market penetration by improving access to post-chemotherapy supportive care without requiring hospital return visits. Immunological disorders-such as rheumatoid arthritis, Crohn’s disease, and psoriasis-also represent major markets, with biologics like adalimumab and ustekinumab increasingly reformulated for wearable delivery.

North America leads the market due to high biologic adoption, strong reimbursement frameworks, and favorable regulatory pathways for combination products. Europe follows closely, supported by chronic disease prevalence and homecare system expansion. Asia-Pacific is a growing frontier, particularly in Japan and South Korea, where aging populations and advanced pharmaceutical infrastructure are creating favorable conditions for OBDD adoption. In emerging markets, pharma partnerships and telehealth-enabled outreach programs are helping to bridge accessibility gaps, positioning OBDDs as a key component in community-level chronic care models.

What Is Driving Long-Term Growth and Strategic Innovation in the On-Body Drug Delivery Devices Market?

The growth in the on-body drug delivery devices market is driven by rising biologic usage, evolving patient-centric care models, and the need to reduce healthcare system burdens. The COVID-19 pandemic accelerated the shift to self-administered treatments, highlighting the relevance of OBDDs in ensuring continuity of care during system disruptions. Increasing payer interest in outcomes-based reimbursement is also prompting adoption of technologies that improve adherence and real-world efficacy.

Device manufacturers are investing in modular platforms that support a range of volumes, viscosities, and drug stabilities. Sustainable design-including recyclable components and reduced plastic use-is gaining importance amid environmental scrutiny. Co-development partnerships between biotech companies and device manufacturers are becoming standard, enabling drug-device combination products to achieve faster regulatory clearance and market entry. As biologics continue to dominate pharmaceutical pipelines, and as digital health becomes integral to chronic disease management, on-body delivery devices will evolve into multifunctional, intelligent health companions that extend the reach of specialty care beyond traditional clinical settings.

SCOPE OF STUDY:

The report analyzes the On-Body Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Wearable Injectors, Auto-injectors, Patches, Other Product Types); Application (Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application, Other Applications); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Ablitech, Inc.
• BD (Becton, Dickinson and Company)
• BioSapien Inc.
• Coherus BioSciences, Inc.
• Convatec Group plc
• Eitan Medical
• Elcam Medical
• Enable Injections
• Gerresheimer AG
• Intarcia Therapeutics
• Johnson & Johnson
• Medtronic plc
• Nemera
• NOVO Engineering
• Phillips-Medisize
• Roche Holding AG
• SHL Medical
• Stevanato Group
• Tandem Diabetes Care, Inc.
• Ypsomed AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • On-Body Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Patient-Centric Drug Delivery Drives Growth in On-Body Wearable Devices
  • Increase in Biologic Drug Approvals Spurs Adoption of Large-Volume Subcutaneous Delivery Systems
  • Expansion of Home-Based Care Models Strengthens Business Case for Self-Administered On-Body Devices
  • Surge in Chronic Disease Prevalence Throws the Spotlight on Long-Term and Sustained Drug Delivery Technologies
  • Advancements in Smart Wearable Injectors Drive Real-Time Monitoring and Dosing Precision
  • Rising Regulatory Support for Connected Devices Enhances Market Readiness for Digital Health Integration
  • Availability of Integrated Sensors and Alarms Improves Compliance and Enhances Patient Safety
  • Shift Toward Prefilled, Disposable Systems Propels Demand for Low-Maintenance Drug Delivery Solutions
  • Growth in Oncology and Immunotherapy Treatments Supports Expansion of On-Body Device Pipelines
  • Increasing Pharmaceutical-Biotech Collaborations Enable Co-Development of Drug-Device Combinations
  • Adoption of Wearable Patch Pumps in Diabetes Management Expands Use in Adjacent Therapeutic Areas
  • Supply Chain Optimization and Device Standardization Drive Cost-Efficient Mass Production
  • Challenges in Battery Life and Device Adhesion Highlight Opportunities for Technical Innovation
  • Global Emphasis on Reducing Hospital Readmissions Supports Shift to Ambulatory Drug Delivery Models
  • Use of Connectivity and Cloud Platforms Facilitates Integration With EHR and Remote Monitoring Systems
  • Growing Investment in Human Factors Engineering Enhances User-Friendly Device Design
  • Demand for Reduced Injection Frequency Enhances Uptake of Long-Acting On-Body Delivery Formats
  • Regulatory Focus on Post-Market Surveillance and Real-World Data Strengthens Adoption Confidence
  • Rising Patient Awareness and Tech Literacy Levels Expand Market Acceptance of On-Body Delivery Platforms
  • Expansion of CDMO Services for Drug-Device Combination Products Accelerates Go-to-Market Strategy
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World On-Body Drug Delivery Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for On-Body Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Wearable Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Wearable Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Wearable Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Auto-injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Auto-injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Auto-injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cardiovascular Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Autoimmune Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Diabetes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for On-Body Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for On-Body Drug Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for On-Body Drug Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION